Posted on: September 21, 2021
Infinity BiologiX, Cytox, and Vanguard Pharma announce the US launch of the first, physician use only, polygenic test to predict the risk of cognitive decline due to Alzheimer’s disease.
Posted on: September 15, 2021
Leader in Biomaterial expertise, Infinity BiologiX, increases global footprint and capabilities with expansion into Europe with key acquisition. IBX, a... View Article
Posted on: June 23, 2021
Cytox Collaboration Infinity BiologiX and Cytox collaborate to provide new genetic test to predict the risk of cognitive decline due... View Article
Posted on: June 18, 2021
Senior Team Members Announcement Infinity BiologiX announces new senior team members including Robin Grimwood as CEO Infinity BiologiX, LLC (IBX),... View Article
Posted on: May 25, 2021
Supporting the COVID-19 Response in India Infinity BiologiX (IBX) Donates $50,000 to Sewa International and UNICEF USA to Support COVID-19... View Article
Posted on: April 13, 2021
CDC Contract Infinity BiologiX (IBX) Awarded CDC Contract to Sequence Variants of COVID-19 Virus and Assist in Global Public Health... View Article
Posted on: March 31, 2021
Ginkgo Bioworks Collaboration Infinity BiologiX (IBX) Announces Collaboration With Ginkgo Bioworks to Scale COVID Response Through Pooled Testing in K-12... View Article
Posted on: February 14, 2021
Dr. Shareef Nahas Joins IBX Infinity BiologiX Names Dr. Shareef Nahas as Vice President of Global Laboratory Operations and Clinical... View Article
Posted on: September 15, 2020
Helping Schools and Companies Reopen Safely During COVID-19 Telehealth Company, justmiine, Launches One-of-a-kind Platform, miinehealth, To Help Schools And Companies... View Article
Posted on: September 14, 2020
Viroclinics-DDL and Infinity BiologiX Deepen Their Partnership The two companies bring their existing partnership to the next level by developing... View Article